Status:
ACTIVE_NOT_RECRUITING
Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type
Lead Sponsor:
Institut du Cancer de Montpellier - Val d'Aurelle
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim is to validate a signature of microRNA (micro Ribonucleic acid) based in a first exploratory study allowing the stratification of the cytologies of indeterminate type and to study and select o...
Detailed Description
Morphological analysis of fine-needle aspiration cytology (FNAC) under ultrasound classifies thyroid nodules in 6 categories (Bethesda classification). The diagnostic approach is codified by the Socie...
Eligibility Criteria
Inclusion
- Man or woman whose Age is ≥ 18 years
- Patient requiring ultrasound for thyroid nodule scanning with established indication of FNAC
- Patient with Bethesda 3, 4 and 5 thyroid nodule
- Informed patient and signed informed consent received
- Patient affiliated to a French medical coverage system
Exclusion
- Patient under guardianship, curatorship or safeguarding of justice
- Patient whose medical or psychological conditions do not permit them to complete the study or to sign the consent,
- Patient with metastatic cancer distinct from thyroid cancer
- Patient who has stopped treatment (chemotherapy / immunotherapy) for cancer for less than 6 months.
Key Trial Info
Start Date :
June 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT04285476
Start Date
June 17 2021
End Date
December 1 2026
Last Update
September 23 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Toulouse
Toulouse, Haute-Garonne, France, 31000
2
Institut régional du Cancer de Montpellier
Montpellier, Hérault, France, 34298
3
CHU de Nîmes
Nîmes, France, 30029